{
    "ticker": "BXRXQ",
    "name": "Baudax Bio, Inc.",
    "description": "Baudax Bio, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapeutics for patients in need. Established in 2018 and headquartered in Malvern, Pennsylvania, Baudax Bio is dedicated to addressing unmet medical needs in the areas of pain management and other critical conditions. The company's flagship product, Anjeso, is a novel injectable formulation of meloxicam, designed to provide an effective pain management solution while minimizing the risk of opioid misuse. With a strong commitment to advancing medical science, Baudax Bio is actively engaged in research and development to expand its product pipeline and further enhance treatment options for healthcare providers and their patients. The company aims to redefine the standards of care in pain management and improve patient outcomes through its focus on innovative, non-opioid therapies. Baudax Bio is committed to fostering partnerships with healthcare professionals, patients, and stakeholders to promote the safe and effective use of its products, contributing to a healthier future for all.",
    "industry": [
        "Biopharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Malvern, Pennsylvania, USA",
    "founded": "2018",
    "website": "https://www.baudaxbio.com",
    "ceo": "Gordon R. McDougall",
    "social_media": {
        "twitter": "https://twitter.com/BaudaxBio",
        "linkedin": "https://www.linkedin.com/company/baudax-bio/"
    },
    "investor_relations": "https://www.baudaxbio.com/investors",
    "key_executives": [
        {
            "name": "Gordon R. McDougall",
            "position": "CEO"
        },
        {
            "name": "Michael D. McCarthy",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pain Management",
            "products": [
                "Anjeso"
            ]
        }
    ],
    "seo": {
        "meta_title": "Baudax Bio, Inc. | Innovative Pain Management Solutions",
        "meta_description": "Explore Baudax Bio, Inc., a biopharmaceutical company focused on innovative therapeutics for pain management. Learn about Anjeso and our commitment to improving patient care.",
        "keywords": [
            "Baudax Bio",
            "Anjeso",
            "Pain Management",
            "Biopharmaceuticals",
            "Healthcare Innovation"
        ]
    },
    "faq": [
        {
            "question": "What is Baudax Bio known for?",
            "answer": "Baudax Bio is known for its innovative pain management solutions, particularly its product Anjeso."
        },
        {
            "question": "Who is the CEO of Baudax Bio?",
            "answer": "Gordon R. McDougall is the CEO of Baudax Bio, Inc."
        },
        {
            "question": "Where is Baudax Bio headquartered?",
            "answer": "Baudax Bio is headquartered in Malvern, Pennsylvania, USA."
        },
        {
            "question": "What is Anjeso?",
            "answer": "Anjeso is an injectable formulation of meloxicam, developed for effective pain management."
        },
        {
            "question": "When was Baudax Bio founded?",
            "answer": "Baudax Bio was founded in 2018."
        }
    ],
    "competitors": [
        "HGEN",
        "PTGX",
        "AVXL"
    ],
    "related_stocks": [
        "AMGN",
        "JNJ",
        "PFE",
        "MRNA"
    ]
}